John M Kirkwood Selected Research

John M Kirkwood Research Topics

Disease

262	Melanoma (Melanoma, Malignant) 11/2022 - 01/2002
147	Neoplasms (Cancer) 12/2022 - 01/2002
32	Neoplasm Metastasis (Metastasis) 01/2022 - 03/2002
9	Disease Progression 01/2021 - 06/2011
8	Brain Neoplasms (Brain Tumor) 01/2021 - 06/2004
8	Exanthema (Rash) 01/2021 - 06/2011
7	Fatigue 09/2017 - 09/2002
7	Renal Cell Carcinoma (Grawitz Tumor) 12/2016 - 09/2002
7	Diarrhea 01/2015 - 06/2009
6	Neutropenia 08/2015 - 10/2006
5	Nevus (Nevi) 01/2021 - 01/2003
5	Lymphatic Metastasis 01/2019 - 07/2006
5	Colitis 01/2016 - 01/2012
4	Uveal melanoma 01/2021 - 01/2019
4	Human Influenza (Influenza) 01/2014 - 09/2002
3	Inflammation (Inflammations) 01/2021 - 03/2010
3	Fever (Fevers) 01/2021 - 07/2009
3	Hemorrhage 01/2020 - 10/2006
3	Infections 01/2019 - 10/2006
3	Tetanus 08/2013 - 11/2009
2	Virus Diseases (Viral Diseases) 12/2022 - 01/2015
2	Pneumonia (Pneumonitis) 01/2022 - 08/2015
2	COVID-19 01/2022 - 01/2021
2	Testicular Neoplasms (Testicular Cancer) 01/2021 - 01/2014

Drug/Important Bio-Agent (IBA)

44	InterferonsIBA 11/2021 - 01/2002
32	AntigensIBA 11/2021 - 09/2002
31	VaccinesIBA 11/2021 - 03/2002
28	Biomarkers (Surrogate Marker)IBA 12/2022 - 04/2007
28	IpilimumabIBA 01/2022 - 12/2010
27	Peptides (Polypeptides)IBA 01/2022 - 01/2002
26	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2002
20	Interleukin-2 (IL2)IBA 01/2022 - 01/2002
17	CytokinesIBA 01/2021 - 03/2002
16	Immune Checkpoint InhibitorsIBA 12/2022 - 09/2010
16	Dacarbazine (DIC)FDA LinkGeneric 01/2021 - 04/2004
14	EpitopesIBA 01/2018 - 01/2002
13	pembrolizumabIBA 01/2022 - 01/2015
12	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 09/2008
12	dabrafenibIBA 01/2021 - 07/2012
11	Neoplasm Antigens (Tumor Antigens)IBA 01/2022 - 07/2006
11	Cancer VaccinesIBA 12/2020 - 01/2002
10	trametinibIBA 01/2021 - 03/2017
10	Monoclonal AntibodiesIBA 01/2021 - 10/2008
10	HLA-DR Antigens (HLA-DR)IBA 01/2014 - 01/2002
9	Interferon-alpha (Interferon Alfa)IBA 01/2022 - 04/2002
9	Biological ProductsIBA 01/2021 - 06/2008
9	Pharmaceutical PreparationsIBA 01/2021 - 02/2009
9	VemurafenibIBA 01/2021 - 06/2011
9	Interferon alpha-2 (Roferon-A)FDA Link 01/2020 - 03/2002
8	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021 - 05/2004
8	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 09/2017 - 11/2009
8	tremelimumabIBA 01/2017 - 10/2007
8	Temozolomide (Temodar)FDA LinkGeneric 12/2015 - 01/2003
7	NivolumabIBA 11/2020 - 01/2015
7	Paclitaxel (Taxol)FDA LinkGeneric 01/2016 - 08/2006
6	EnzymesIBA 11/2021 - 03/2002
6	LigandsIBA 12/2020 - 09/2004
6	Phosphotransferases (Kinase)IBA 01/2020 - 03/2007
6	Carboplatin (JM8)FDA LinkGeneric 01/2016 - 06/2009
6	Sorafenib (BAY 43-9006)FDA Link 01/2016 - 06/2009
5	Programmed Cell Death 1 ReceptorIBA 11/2021 - 05/2015
4	Dasatinib (BMS 354825)FDA Link 11/2021 - 01/2014
4	AntibodiesIBA 01/2021 - 01/2002
4	incomplete Freund's adjuvantIBA 01/2021 - 11/2009
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 02/2006
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2018 - 04/2007
4	ChemokinesIBA 01/2015 - 04/2007
4	Monophenol Monooxygenase (Tyrosinase)IBA 08/2012 - 09/2004
3	Tyrosine Kinase InhibitorsIBA 11/2021 - 06/2014
3	HLA Antigens (Human Leukocyte Antigens)IBA 11/2021 - 09/2010
3	Histone Deacetylases (Histone Deacetylase)IBA 01/2021 - 11/2006
3	cobimetinibIBA 11/2020 - 07/2012
3	Interferon Type IIBA 01/2019 - 10/2007
3	Protein Subunit VaccinesIBA 09/2017 - 02/2009
3	RNA (Ribonucleic Acid)IBA 01/2017 - 03/2004
3	Interleukin-10 (Interleukin 10)IBA 04/2015 - 08/2010
3	MicroRNAs (MicroRNA)IBA 01/2015 - 09/2009
3	Cisplatin (Platino)FDA LinkGeneric 11/2014 - 06/2004
3	CTLA-4 AntigenIBA 11/2014 - 10/2008
3	ProMune (CpG 7909)IBA 05/2012 - 10/2008
3	InterleukinsIBA 04/2011 - 04/2007
3	Immunodominant EpitopesIBA 01/2011 - 08/2006
3	Immunoglobulin G (IgG)IBA 03/2010 - 10/2007
3	Interferon-alpha2bIBA 02/2009 - 04/2007
3	Indicators and Reagents (Reagents)IBA 02/2008 - 01/2003
2	neratinibIBA 01/2022 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 04/2007
2	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 10/2020
2	Histone Deacetylase InhibitorsIBA 01/2022 - 03/2017
2	Toll-Like Receptor 9IBA 12/2021 - 05/2009

Therapy/Procedure

127	Therapeutics 12/2022 - 01/2002
53	Immunotherapy 12/2022 - 03/2002
28	Drug Therapy (Chemotherapy) 01/2021 - 01/2003
9	Neoadjuvant Therapy 01/2021 - 07/2006
7	Radiotherapy 05/2013 - 06/2004
5	Biological Therapy 11/2014 - 03/2002
4	Lymph Node Excision (Lymph Node Dissection) 02/2018 - 07/2006
4	Aftercare (After-Treatment) 01/2016 - 06/2004
3	Chemoprevention 01/2019 - 08/2008
3	Immunomodulation 01/2011 - 12/2007